Rare nasal cancer under the microscope: new study aims to unlock secrets
NCT ID NCT04755205
First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 14 times
Summary
This study is following children and adults with olfactory neuroblastoma, a rare cancer of the nasal cavity, to learn more about how the disease behaves over time. Researchers will collect medical records, blood samples, and survey responses from 525 participants to track symptoms, treatment responses, and outcomes. The goal is to better understand the disease and pave the way for improved treatments and supportive care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could provide crucial insights into how olfactory neuroblastoma progresses and responds to treatments, guiding better care strategies.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly test new therapies. Results may take years and might not lead to immediate changes in care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESTHESIONEUROBLASTOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- How do patients feel after Nose-Based brain surgery? new study aims to find out
- Promising combo targets Hard-to-Treat childhood cancers
- New brain scan could spot tumors missed by standard MRI
- New radiation drug targets Hard-to-Treat cancers
- New radioactive drug combo takes aim at returning head and neck cancers
- Targeted pill takes on rare skull base cancers